Filing Details
- Accession Number:
- 0001209191-22-061541
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-15 19:24:40
- Reporting Period:
- 2022-12-13
- Accepted Time:
- 2022-12-15 19:24:40
- SEC Url:
- Form 4 Filing
Issuer
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1240590 | J Daniel Levin | 900 Jefferson Ave Redwood City CA 94063 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2022-12-13 | 50,000 | $4.63 | 50,000 | No | 4 | M | Indirect | See footnote |
Class A Common Stock | Acquisiton | 2022-12-13 | 6,340 | $17.85 | 56,340 | No | 4 | M | Indirect | See footnote |
Class A Common Stock | Acquisiton | 2022-12-13 | 73,506 | $17.85 | 129,846 | No | 4 | M | Indirect | See footnote |
Class A Common Stock | Acquisiton | 2022-12-13 | 1 | $14.05 | 129,847 | No | 4 | M | Indirect | See footnote |
Class A Common Stock | Disposition | 2022-12-13 | 73,506 | $31.39 | 56,341 | No | 4 | S | Indirect | See footnote |
Class A Common Stock | Acquisiton | 2022-12-14 | 76,494 | $17.85 | 132,835 | No | 4 | M | Indirect | See footnote |
Class A Common Stock | Disposition | 2022-12-14 | 76,494 | $31.56 | 56,341 | No | 4 | S | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Indirect | See footnote |
No | 4 | M | Indirect | See footnote |
No | 4 | M | Indirect | See footnote |
No | 4 | M | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
No | 4 | M | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class A Common Stock | Employee Stock Option (right to buy) | Disposition | 2022-12-13 | 50,000 | $0.00 | 50,000 | $4.63 |
Class A Common Stock | Employee Stock Option (right to buy) | Disposition | 2022-12-13 | 6,340 | $0.00 | 6,340 | $17.85 |
Class A Common Stock | Employee Stock Option (right to buy) | Disposition | 2022-12-13 | 73,506 | $0.00 | 73,506 | $17.85 |
Class A Common Stock | Employee Stock Option (right to buy) | Disposition | 2022-12-13 | 1 | $0.00 | 1 | $14.05 |
Class A Common Stock | Employee Stock Option (right to buy) | Disposition | 2022-12-14 | 76,494 | $0.00 | 76,494 | $17.85 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2023-04-19 | No | 4 | M | Indirect | |
0 | 2024-04-02 | No | 4 | M | Indirect | |
220,154 | 2024-04-02 | No | 4 | M | Indirect | |
0 | 2025-01-02 | No | 4 | M | Indirect | |
143,660 | 2024-04-02 | No | 4 | M | Indirect |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Class A Common Stock | 36,888 | Direct |
Footnotes
- The shares are held of record by Daniel J. Levin and Naomi J. Andrews, as Trustees of the Levin/Andrews Family Trust.
- This sale price represents the weighted average sale price of the shares sold ranging from $31.11 to $31.63 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- This sale price represents the weighted average sale price of the shares sold ranging from $31.09 to $31.99 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- All of this option grant's shares became fully exercisable as of 02/01/2017.
- All of this option grant's shares became fully exercisable as of 01/01/2018.
- All of this option grant's shares became fully exercisable as of 02/01/2018.
- 1 of this option grant's shares became fully exercisable as of 01/20/2017. The remaining options were subsequently cancelled due to the terms of the grant.